Baxter to divest biopharma solutions business to Advent International and Warburg Pincus for $4.25 bn Read more
Enzene Biosciences raises $50 million to boost manufacturing capabilities and grow in global markets Read more
We will maintain a growth rate in the high teens for both (CDMO and API business) in the next few years Read more
Piramal Pharma Solutions expands in-vitro biology capabilities at Ahmedabad Discovery Services Site Read more